98%
921
2 minutes
20
Background/aim: This study aimed to investigate the association between the perioperative usage of hyaluronic acid (HA)-containing artificial tears and the refractive accuracy of cataract surgery in patients with dry eye disease (DED).
Patients And Methods: In this retrospective cohort study, patients with DED who underwent cataract surgery were categorized based on their use of HA-containing artificial tears. A total of 62 eyes were assigned to the non-HA group and 54 eyes to the HA group. The primary outcomes were the uncorrected distance visual acuity (UDVA), postoperative spherical equivalent (SE), and astigmatism assessed vector analysis. The independent t test and the generalized linear regression were applied for the statistical analysis.
Results: Three months postoperatively, the UDVA in the HA group was significantly better than that in the non-HA group (<0.001). At the same time, the residual SE was significantly higher in the non-HA group than in the HA group ( =0.001). In addition, the HA group showed a higher surgery-induced astigmatism (SIA), lower difference vector (DV), lower magnitude of error (ME), and higher correction index (CoI) compared to the non-HA group (all >0.05). The high axial length (AXL) significantly correlated to the higher residual SE in the HA group (=0.001), while the low preoperative tear break-up time, high corneal astigmatism and high AXL correlated to the higher residual SE in the non-HA group (all <0.05).
Conclusion: Perioperative use of HA-containing artificial tears is associated with improved refractive accuracy following cataract surgery in patients with DED.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12396046 | PMC |
http://dx.doi.org/10.21873/invivo.14094 | DOI Listing |
J Refract Surg
September 2025
Purpose: To evaluate tilt, decentration, and axial stability of the Clareon toric intraocular lens (TIOL) (CNW0T3-9; Alcon Laboratories, Inc) over a 6-month follow-up period.
Methods: A single-center, prospective, interventional clinical trial was conducted with a study population of 130 eyes from 82 patients who received a Clareon TIOL. Tilt, decentration, and the aqueous depth were determined preoperatively and at 1 week and 6 months postoperatively using anterior segment optical coherence tomography (Casia 2; Tomey Corporation).
Purpose: To evaluate visual and refractive outcomes, visual quality, patient satisfaction, and spectacle independence 3 months after phacoemulsification with bilateral non-diffractive enhanced depth of focus (EDOF) lens implantation.
Methods: This study included 68 eyes of 34 consecutive patients, with 51.5% undergoing refractive lens exchange and 48.
J Refract Surg
September 2025
From the Department of Ophthalmology, Goethe-University, Frankfurt am Main, Germany and.
Purpose: To evaluate intraocular lens (IOL) power calculation of a non-diffractive extended depth of focus (EDOF) IOL after myopic laser in situ keratomileusis (LASIK) without historical data.
Methods: In this consecutive case series, patients who had undergone lens surgery with implantation of a non-diffractive EDOF IOL after myopic laser in situ keratomileusis (LASIK) at the Department of Ophthalmology, University Hospital Frankfurt, Frankfurt, Germany, were included. Preoperative assessments included biometry and tomography using Scheimpflug technology (Pentacam; Oculus Optikgeräte GmbH).
J Refract Surg
September 2025
From the Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Purpose: To determine the accuracy of a new machine learning-based open-source IOL formula (PEARLS-DGS) in 100 patients who underwent uncomplicated cataract surgery and had a history of laser refractive surgery for myopic defects.
Methods: The setting for this retrospective study was HUMANITAS Research Hospital, Milan, Italy. Data from 100 patients with a history of photorefractive keratectomy or laser in situ keratomileusis were retrospectively analyzed to assess the accuracy of the formula.
J Refract Surg
September 2025
From Qvision, Department of Ophthalmology of VITHAS Almería Hospital, Almería, Spain.
Purpose: To assess differences in intraocular lens (IOL) power calculation prediction error (PE) considering the manufacturing tolerance or exact power (EP) versus labeled power (LP), and to compare accuracy using the Barrett formula with optimized constant versus a thick-lens formula.
Methods: The PE and absolute PE were calculated for a random eye of patients implanted with the multifocal Liberty Q-Flex 640PM IOL (Medicontur Ltd) considering the LP and the EP provided by the manufacturer. The outcomes for the Barrett with optimized constant formula and a thick-lens formula personalized for the surgeon, biometer, and IOL were compared.